help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asch, S. M.
Right arrow Articles by Gelberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asch, S. M.
Right arrow Articles by Gelberg, L.

Am. J. Respir. Crit. Care Med., Vol 155, No. 1, Jan 1997, 378-381.

Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles

SM Asch, AS London, PF Barnes and L Gelberg
Division of General Internal Medicine, Pacific Center for Health Policy and Ethics, University of Southern California School of Medicine, Los Angeles, USA.

To investigate patterns of testing for human immunodeficiency virus (HIV) infection in tuberculosis patients, we obtained data from the tuberculosis registry and from medical records of 500 tuberculosis patients in Los Angeles County. Sixty-three percent of tuberculosis patients were tested for HIV infection, and multivariate logistic regression analysis revealed that the likelihood of testing was significantly higher among males, persons between 20 and 49 yr old, individuals with HIV risk factors, and patients treated by public health care providers. A minimum of 12% of the total sample, 2% of females, 2% of those outside the ages of 20 to 49, 7% of patients without recorded HIV risk factors, and 17% of patients treated by private practitioners were infected with HIV. These results suggest that health care providers, particularly private practitioners, do not follow national recommendations for universal HIV testing of tuberculosis patients. Instead, HIV testing is preferentially performed on patients perceived to be at high risk for HIV infection. Because HIV seroprevalence is at least 2 to 7% in "low-risk" groups, failure to test these patients may result in significant missed opportunities for diagnosis and treatment of HIV coinfection.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. Chou, L. H. Huffman, R. Fu, A. K. Smits, and P. T. Korthuis
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, July 5, 2005; 143(1): 55 - 73.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
J. Walkup, J. Satriano, D. Barry, P. Sadler, and F. Cournos
HIV Testing Policy and Serious Mental Illness
Am J Public Health, December 1, 2002; 92(12): 1931 - 1940.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Lauzardo and D. Ashkin
Phthisiology at the Dawn of the New Century
Chest, May 1, 2000; 117(5): 1455 - 1473.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. V. Havlir and P. F. Barnes
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
N. Engl. J. Med., February 4, 1999; 340(5): 367 - 373.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society